Current Health, an artificial intelligence (AI)-powered wearable, has announced it received Class II clearance from the Food and Drug Administration (FDA) for hospital care. Current is a wireless device that continuously and automatically monitors patients to help better determine health trajectory and allows clinicians to intervene earlier.
Current’s approach may help health organizations reduce unnecessary hospital readmissions for patients whose conditions deteriorate after treatment — an expensive and cumbersome clinical burden that costs U.S. hospitals more than $40 billion annually.
Built using a large real-time physiological data set, Current is an all-in-one wireless wearable that uses the company’s proprietary algorithms to continuously analyze data, along with relevant contextual patient information, to offer actionable and proactive insights into the wearer’s health. It integrates with third-party devices to capture additional metrics, building patient-specific digital therapeutics and recommendations.
Current is demonstrating its FDA-cleared solution at the HIMSS19 trade show in Orlando from February 11 to 14 at Booth 5359-05.
